EA200702386A1 - Твердая фармацевтическая композиция для продолжительного высвобождения 1-(2,3,4-триметоксибензил)пиперазина и способ ее получения - Google Patents

Твердая фармацевтическая композиция для продолжительного высвобождения 1-(2,3,4-триметоксибензил)пиперазина и способ ее получения

Info

Publication number
EA200702386A1
EA200702386A1 EA200702386A EA200702386A EA200702386A1 EA 200702386 A1 EA200702386 A1 EA 200702386A1 EA 200702386 A EA200702386 A EA 200702386A EA 200702386 A EA200702386 A EA 200702386A EA 200702386 A1 EA200702386 A1 EA 200702386A1
Authority
EA
Eurasian Patent Office
Prior art keywords
piperazine
pharmaceutical composition
solid pharmaceutical
trimetoxibenzyl
exemption
Prior art date
Application number
EA200702386A
Other languages
English (en)
Other versions
EA013645B1 (ru
Inventor
Жером Бессе
Original Assignee
Ле Лаборатуар Сервье
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ле Лаборатуар Сервье filed Critical Ле Лаборатуар Сервье
Publication of EA200702386A1 publication Critical patent/EA200702386A1/ru
Publication of EA013645B1 publication Critical patent/EA013645B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers

Abstract

Твердая фармацевтическая композиция продолжительного высвобождения, которая включает активный ингредиент 1-(2,3,4-триметоксибензил)пиперазин или фармацевтически приемлемую соль 1-(2,3,4-триметоксибензил)пиперазина, в комбинации по крайней мере с одним полиэтиленоксидом и по крайней мере одним смазывающим агентом и одним или более фармацевтически приемлемыми наполнителями.
EA200702386A 2005-05-18 2006-02-13 Твердая фармацевтическая композиция с пролонгированным высвобождением 1-(2,3,4-триметоксибензил)пиперазина и способ ее получения EA013645B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0504997A FR2885807B1 (fr) 2005-05-18 2005-05-18 Composition pharmaceutique solide a liberation prolongee de 1-(2,3,4-trimethoxybenzyl) piperazine, et procede de preparation
PCT/FR2006/050128 WO2006123073A1 (fr) 2005-05-18 2006-02-13 Composition pharmaceutique solide a liberation prolongee de 1-(2,3,4-trimethoxybenzyl)piperazine, et procede de preparation.

Publications (2)

Publication Number Publication Date
EA200702386A1 true EA200702386A1 (ru) 2008-04-28
EA013645B1 EA013645B1 (ru) 2010-06-30

Family

ID=35583424

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200702386A EA013645B1 (ru) 2005-05-18 2006-02-13 Твердая фармацевтическая композиция с пролонгированным высвобождением 1-(2,3,4-триметоксибензил)пиперазина и способ ее получения

Country Status (5)

Country Link
EP (1) EP1881831A1 (ru)
EA (1) EA013645B1 (ru)
FR (1) FR2885807B1 (ru)
UA (1) UA89408C2 (ru)
WO (1) WO2006123073A1 (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0815602A2 (pt) * 2007-08-08 2015-03-03 Usv Ltd Composições de liberação prolongada de trimetazidina e processo para a preparação das mesmas
EP2200591A2 (en) * 2007-09-11 2010-06-30 Ranbaxy Laboratories Limited Controlled release pharmaceutical dosage forms of trimetazidine
JP2012515757A (ja) * 2009-01-20 2012-07-12 マイクロ ラブス リミテッド トリメタジジンの放出調節固形薬剤組成物及びその製造方法
TR201001902A2 (tr) * 2010-03-12 2011-04-21 Ali̇ Rai̇f İlaç Sanayi̇ Ve Ti̇caret A.Ş. Uzatılmış salınımlı trimetazidin tablet
PL2394644T3 (pl) * 2010-05-04 2014-11-28 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Preparat trimetazydyny o różnych profilach uwalniania

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2717687B1 (fr) * 1994-03-24 1996-06-14 Adir Compositions pharmaceutiques permettant la libération prolongée de trimétazidine après administration par voie orale.
FR2802424B1 (fr) * 1999-12-17 2002-02-15 Adir Comprime matriciel permettant la liberation prolongee de trimetazidine apres administration par voie orale
DE60042972D1 (de) * 2000-10-05 2009-10-29 Usv Ltd Trimetazidine enthaltendes Arzneimittel mit verzögerter Wirkstoffabgabe und Verfahren zur Herstellung
FR2818549B1 (fr) * 2000-12-26 2003-02-07 Servier Lab Composition pharmaceutique solide thermoformable pour la liberation controlee de trimetazidine
HUP0500382A3 (en) * 2001-11-21 2008-03-28 Themis Lab Private Ltd Sustained release pharmaceutical compositions containing microbeads of trimetazidine dihydrochloride and process for producing them

Also Published As

Publication number Publication date
FR2885807B1 (fr) 2008-05-16
FR2885807A1 (fr) 2006-11-24
EP1881831A1 (fr) 2008-01-30
EA013645B1 (ru) 2010-06-30
WO2006123073A1 (fr) 2006-11-23
UA89408C2 (ru) 2010-01-25

Similar Documents

Publication Publication Date Title
NO20076613L (no) Farmasoytiske formuleringer og anvendelse derav
WO2007008752A3 (en) Sustained release pharmaceutical compositions for highly water soluble drugs
TW200609005A (en) Film-coated tablet with plural coating-layers
BRPI0113331B8 (pt) derivados de fenilalanina ou seus sais parmaceuticamente aceitáveis, antagonista de integrina alfa 4, agente terapêutico ou agente preventivo para doenças inflamatórias, e, composição farmacêutica
WO2007072503A3 (en) Combinations for managing inflammation and associated disorders
TW200640487A (en) Combination of XOLAIR with immunosuppressive agent
DK1792927T3 (da) Ny blokcopolymer, micelletilberedning og anticancermiddel indeholdende samme som aktiv ingrediens
UA90518C2 (ru) Фармацевтическая композиция в форме таблетки, которая имеет улучшеное всасывание при трансбукальном введение, которая содержит наркотический активный ингредиент и амин
EP1993567A4 (en) PER OS ADMINISTRABLE GALLIUM PREPARATIONS AND METHODS OF USE
EP1774968A4 (en) BENZYLISOQUINOLEIN DERIVATIVE OR BISBENZYLISOQUINOLEIN DERIVATIVE - CONTAINING PSYCHOTROPIC, ANALGESIC AND / OR ANTIPHLOGISTIC AGENT, AND HEALTH FOOD.
AR034517A1 (es) Formulacion farmaceutica
RS50768B (sr) Režim doziranja i farmaceutska formulacija za urgentnu zaštitu
UY29952A1 (es) Composiciones faramacéuticas que comprenden 4-(4-fluoro-2-metil-1h-indol-5-iloxi)-6-metoxi-7-(3-(pirrolidin-1-il)propoxi)quinazolina o una sal farmacéuticamente aceptable del mismo, procesos de preparación y uso
ATE260650T1 (de) Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac
DE69923336D1 (de) Oral anzuwendende buprenorphinhaltige arzneimittel
EA200702386A1 (ru) Твердая фармацевтическая композиция для продолжительного высвобождения 1-(2,3,4-триметоксибензил)пиперазина и способ ее получения
ATE357928T1 (de) Pharmazeutische zusammensetzung für thrombinpeptidderivaten
SE0302488D0 (sv) New combination
NO20010863L (no) Nye orale formuleringer for 5-HT4-agonister eller - antagonister
ITMI20022292A1 (it) 9a-azalidi ad attivita' antiinfiammatoria.
BR0112847A (pt) Uso de uma forma de dosagem sólida
MXPA03010054A (es) Composiciones que comprenden lopinavir y metodos para aumentar la biodisponibilidad de agentes farmaceuticos.
BR0116060A (pt) Composição farmacêutica de dronedarona para administração parenteral
BRPI0412364A (pt) composição farmacêutica sólida, compreendendo amisulpride
ITRM20030363A0 (it) Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico diesse.

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU